You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dance/movement therapy

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Trial in Brussels (Therapeutic patient education : oral semi-structured interview, Therapeutic patient education :

Recruiting
  • Cancer
  • Therapeutic patient education : oral semi-structured interview
  • Therapeutic patient education : booklet (passive)
  • Brussels, Belgium
    Cliniques universitaires Saint-Luc
Jan 5, 2022

COVID-19 in Rheumatic Inflammatory Diseases Under

Active, not recruiting
  • Chronic Inflammatory Rheumatism
  • Biological samples
  • Montpellier, Occitanie, France
    Centre hopsitalier universitaire de Montpellier
Jun 10, 2022

Sexually Transmitted Diseases Trial (Doxycyclin, Pentoxifylline, Nitazoxanide 500Mg Oral Tablet)

Not yet recruiting
  • Sexually Transmitted Diseases
  • (no location specified)
Jun 8, 2023

ADHD Trial (FRx-001, FRx-003, FRx-004)

Not yet recruiting
  • ADHD
  • FRx-001
  • +2 more
  • (no location specified)
Jan 26, 2023

Erectile Dysfunction Trial in Sohag (hyperbaric oxygen therapy within hyperbaric oxygen therapy chamber.)

Active, not recruiting
  • Erectile Dysfunction
  • hyperbaric oxygen therapy within hyperbaric oxygen therapy chamber.
  • Sohag, Egypt
    Faculty of medicine sohag university
Jun 26, 2022

HIV-1-infection, HIV, PD-L1 Gene Mutation Trial in Beijing (ASC22 1mg/kg, ASC22 2.5mg/kg, Antiretroviral Therapy)

Recruiting
  • HIV-1-infection
  • +2 more
  • ASC22 1mg/kg
  • +3 more
  • Beijing, Beijing, China
    The FifthMedical Center of the General Hospital of thePeoples Li
Jun 28, 2022

Malignant Ascites Trial (Serplulimab, Molgramostim, Hypofractionated radiotherapy/Sterotactic body radiotherapy)

Not yet recruiting
  • Malignant Ascites
  • (no location specified)
Aug 11, 2022

Respiratory Failure, Hypoxemia, Hypoxemic Respiratory Failure Trial in Katowice (NIV, HFNO)

Enrolling by invitation
  • Respiratory Failure
  • +2 more
  • NIV, HFNO
  • Katowice, Poland
    Aleksandra
Dec 14, 2022

Sleep and Circadian Rhythms in Primary Brain Tumors Patients

Enrolling by invitation
  • Sleep Circadian Rhythms
  • Chronodisruption
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 16, 2022

    Acute Ischemic Stroke Trial in China (Mechanical thrombectomy)

    Recruiting
    • Acute Ischemic Stroke
    • Mechanical thrombectomy
    • Zhangzhou, Fujian, China
    • +17 more
    Jan 30, 2023

    Patients With COVID-19 Trial in Tashkent (The drug "Rutan 0.1"., Basic treatment)

    Completed
    • Patients With COVID-19
    • The drug "Rutan 0.1".
    • Basic treatment
    • Tashkent, Uzbekistan
      Erkin Musabaev
    May 15, 2023

    Fibromyalgia Trial in Solna, Uppsala (Internet-delivered exposure-based cognitive behavior therapy, Internet-delivered

    Active, not recruiting
    • Fibromyalgia
    • Internet-delivered exposure-based cognitive behavior therapy
    • Internet-delivered traditional cognitive behavior therapy
    • Solna, Sweden
    • +1 more
    May 31, 2022

    Fluid Overload, Hemodynamic Instability Trial (Net Ultra Filtration Rate)

    Not yet recruiting
    • Fluid Overload
    • Hemodynamic Instability
    • Net Ultra Filtration Rate
    • (no location specified)
    Oct 2, 2023

    Stroke, Engagement, Patient Trial in Sudbury (Hand Therapy using the MyHand System)

    Recruiting
    • Stroke
    • Engagement, Patient
    • Hand Therapy using the MyHand System
    • Sudbury, Ontario, Canada
      Laurentian University
    Sep 22, 2022

    Multiple Myeloma, Refractory Multiple Myeloma, Relapse Multiple Myeloma Trial in New York (MCARH125, MCARH109)

    Recruiting
    • Multiple Myeloma
    • +2 more
    • MCARH125
    • MCARH109
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jun 20, 2022

    Bladder Cancer Trial in Indianapolis, Baltimore, Rockledge (Dovitinib)

    Terminated
    Has Results
    • Bladder Cancer
    • Indianapolis, Indiana
    • +2 more
    Jul 7, 2022

    Radiation Dermatitis Trial (Di-Dak-Sol, White Petrolatum)

    Withdrawn
    • Radiation Dermatitis
    • (no location specified)
    Jan 31, 2022

    PENG and LFCN Block Versus FIC Block for Multimodal Analgesia

    Completed
    • Regional Anesthesia Morbidity
    • +2 more
    • Peripheral nerve blocks
    • Cinisello Balsamo, Milano, Italy
      Ospedale Edoardo Bassini
    Jun 13, 2023

    Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

    Not yet recruiting
    • Pancreatic Cancer
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Sep 16, 2022

    Gastrointestinal Tumors Trial (PTC drug screening)

    Not yet recruiting
    • Gastrointestinal Neoplasms
    • PTC drug screening
    • (no location specified)
    Mar 4, 2022

    Hepatocellular Carcinoma, Atezolizumab-bevacizumab, Response Evaluation Trial in Seoul (Early response evaluation)

    Recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • Early response evaluation
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Feb 28, 2023

    Periodontitis Trial (Perisolv (A), Standard (B))

    Completed
    • Periodontitis
    • Perisolv (A)
    • Standard (B)
    • (no location specified)
    Mar 8, 2023

    Nightmare, Suicidal Ideation, Children, Only Trial in Tulsa (Cognitive Behavioral Therapy for Nightmares in Children)

    Recruiting
    • Nightmare
    • +2 more
    • Cognitive Behavioral Therapy for Nightmares in Children
    • Tulsa, Oklahoma
    • +1 more
    Sep 5, 2023

    Multiple Myeloma in Relapse Trial in Aurora (Selinexor, Pomalidomide, Daratumumab)

    Recruiting
    • Multiple Myeloma in Relapse
    • Aurora, Colorado
      University of Colorado Hospital
    Jan 31, 2023

    Risk Adaptive Scheme for SBRT for Thoracic Nodes Metastases

    Active, not recruiting
    • Thoracic Nodes Metastases
    • Inoperable thoracic nodes metastases
    • Rozzano, Milano, Italy
      Davide Franceschini
    May 3, 2022